Neurological Sciences

Papers
(The H4-Index of Neurological Sciences is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Spectrum of neurological complications following COVID-19 vaccination153
Long-term neurological manifestations of COVID-19: prevalence and predictive factors78
Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health70
Neuropathologic findings of patients with COVID-19: a systematic review64
Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline62
Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations59
Hereditary spastic paraplegia54
Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document53
Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-1952
COVID-19, de novo seizures, and epilepsy: a systematic review51
Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysis51
Cognitive impairment in multiple sclerosis: diagnosis and monitoring51
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters49
Hereditary transthyretin amyloidosis overview49
The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: a systematic review and meta-analysis47
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine46
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients45
Qualitative smell/taste disorders as sequelae of acute COVID-1944
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine43
Epilepsy and quality of life: what does really matter?43
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting42
Neurological manifestations of coronavirus disease 2019: exploring past to understand present41
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-640
Structural and functional connections between the autonomic nervous system, hypothalamic–pituitary–adrenal axis, and the immune system: a context and time dependent stress response network39
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab36
Functional neurological disorder after COVID-19 vaccination35
Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system35
Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-1935
Stroke and digital technology: a wake-up call from COVID-19 pandemic34
Sex and gender differences in migraines: a narrative review33
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-1933
Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)33
Clinical and neurophysiological characterization of muscular weakness in severe COVID-1933
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study33
0.079694986343384